Sinclair Michael 13D and 13G filings for Opiant Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-17 4:52 pm Sale |
2021-08-23 | 13D | Opiant Pharmaceuticals, Inc. OPNT |
Sinclair Michael | 515,170 9.300% |
-230,000 (-30.87%) |
Filing |